1.Prevalence, awareness, treatment and control of hypertension in population older than 15 years of age in Beijing, 2013-2014.
C X WANG ; X G WU ; H J LIU ; S C GUAN ; C B HOU ; H H LI ; X GU ; Z Y ZHANG ; X H FANG
Chinese Journal of Epidemiology 2018;39(2):179-183
<b>Objective:b> To investigate the rates on prevalence, awareness, treatment and control of hypertension in population older than 15 years of age in Beijing, 2013-2014. <b>Methods:b> A cross-sectional survey was conducted in Beijing between 2013-2014. Stratified multistage random sampling method was used to select representative sample of 13 057 Chinese individuals aged over 15 years, from the general population. Blood pressure was measured for three readings at sitting position after resting for at least five minutes with an average reading recorded. A standardized structured questionnaire was developed to collect history of hypertension and antihypertensive treatment. <b>Results:b> A total of 4 663 community residents aged over 15 years were hypertensive among the 13 057 individuals, with the standardized prevalence rate as 32.7%, in Beijing area. The age-standardized prevalence rates of hypertension appeared 34.6% in men and 30.8% in women. The age-and sexstandardized prevalence of hypertension rates were 33.3% in urban and 24.6% in rural areas. The prevalence of hypertension increased with age and appeared higher in men than in women, in urban than in rural residents. Among the hypertensive patients, rates of awareness, treatment and control were 66.8%, 64.6% and 31.6%, respectively. <b>Conclusion:b> High prevalence of hypertension with low rates on awareness and treatment and control, appeared in the general population of Beijing. Related strategies should be developed regarding prevention, control and management of hypertension, to reduce the burden of this disease.
Adolescent
;
Adult
;
Age Distribution
;
Aged
;
Antihypertensive Agents/therapeutic use*
;
Asian People/statistics & numerical data*
;
Awareness
;
Blood Pressure
;
Blood Pressure Determination
;
China/epidemiology*
;
Cross-Sectional Studies
;
Female
;
Health Knowledge, Attitudes, Practice
;
Humans
;
Hypertension/epidemiology*
;
Male
;
Middle Aged
;
Prevalence
;
Rural Population
;
Sex Distribution
;
Surveys and Questionnaires
;
Urban Population
;
Young Adult
2.Lack of efficacy of a herbal preparation (RCM-102) for seasonal allergic rhinitis: a double blind, randomised, placebo-controlled trial
George B LENON ; C G LI ; C DA COSTA ; F C K THIEN ; Y SHEN ; C C L XUE
Asia Pacific Allergy 2012;2(3):187-194
BACKGROUND: A herbal preparation, known as RMIT Chinese Medicine 102 (RCM-102) consisting of eight herbs which demonstrates inhibition of the release of key inflammatory mediators associated with seasonal allergic rhinitis (SAR) was used. This study evaluated the efficacy and safety of RCM-102 for SAR. OBJECTIVE: This study evaluated the efficacy and safety of RCM-102 for SAR. METHODS: This randomised placebo-controlled trial involved subjects aged between 18 and 65 who were randomly assigned to either RCM-102 or a placebo group. After a two-week baseline period, all subjects took either RCM-102 or placebo capsules (two capsules each time, three times daily with a four hour interval) for a period of eight weeks. The primary end-points were the Five-Point Scale symptom scores. Rhinoconjunctivitis Quality of Life Questionnaire, relief medication usage, adverse events, kidney and liver function tests and full blood examination were secondary end-points. Intention-to-treat analysis was applied. RESULTS: One hundred and four subjects were randomised with 52 in each group. Ninety-five subjects (47 and 48 subjects in RCM-102 and placebo groups) completed the trial. Nine subjects withdrew from the study prior to the end of the second treatment week. At the end of the trial, there were no significant differences between the two groups with respect to all outcome measures. There were no liver or kidney function abnormalities reported. CONCLUSION: This mechanism-based RCM-102 was safe but not more beneficial than placebo for patients with SAR.
Asian Continental Ancestry Group
;
Capsules
;
Herbal Medicine
;
Humans
;
Kidney
;
Liver
;
Liver Function Tests
;
Outcome Assessment (Health Care)
;
Plant Preparations
;
Quality of Life
;
Rhinitis, Allergic, Seasonal
;
Seasons
3.A case of human infection with highly pathogenic avian influenza A (H7N9) virus through poultry processing without protection measure.
Y MA ; Z B ZHANG ; L CAO ; J Y LU ; K B LI ; W Z SU ; T G LI ; Z C YANG ; M WANG
Chinese Journal of Epidemiology 2018;39(6):799-804
<b>Objective:b> To investigate the infection pattern and etiological characteristics of a case of human infection with highly pathogenic avian influenza A (H7N9) virus and provide evidence for the prevention and control of human infection with highly pathogenic avian influenza virus. <b>Methods:b> Epidemiological investigation was conducted to explore the case's exposure history, infection route and disease progression. Samples collected from the patient, environments and poultry were tested by using real time reverse transcriptase-polymerase chain reaction (RT-PCR). Virus isolation, genome sequencing and phylogenetic analysis were conducted for positive samples. <b>Results:b> The case had no live poultry contact history, but had a history of pulled chicken processing without taking protection measure in an unventilated kitchen before the onset. Samples collected from the patient's lower respiratory tract, the remaining frozen chicken meat and the live poultry market were all influenza A (H7N9) virus positive. The isolated viruses from these positive samples were highly homogenous. An insertion which lead to the addition of multiple basic amino acid residues (PEVPKRKRTAR/GL) was found at the HA cleavage site, suggesting that this virus might be highly pathogenic. <b>Conclusions:b> Live poultry processing without protection measure is an important infection mode of "poultry to human" transmission of avian influenza viruses. Due to the limitation of protection measures in live poultry markets in Guangzhou, it is necessary to promote the standardized large scale poultry farming, the complete restriction of live poultry sales and centralized poultry slaughtering as well as ice fresh sale.
Animals
;
Chickens
;
China
;
Commerce
;
Humans
;
Influenza A Virus, H7N9 Subtype/pathogenicity*
;
Influenza in Birds/virology*
;
Influenza, Human/virology*
;
Phylogeny
;
Poultry/virology*
;
Real-Time Polymerase Chain Reaction
;
Zoonoses
4.Peroxisomal membrane protein 4 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the ERK1/2 signaling pathway
LI Weia ; XU Zishanb ; MA Keb ; ZHANG Jingyub ; HU Xiaoyuna ; HE Guoyangb,c
Chinese Journal of Cancer Biotherapy 2024;31(8):786-795
[摘 要] 目的:探讨过氧化物酶体膜蛋白4(PXMP4)对肝细胞癌(HCC)细胞迁移和侵袭及上皮间质转化(EMT)进程的影响。方法:采用生物信息学和免疫组织化学方法分析HCC组织中PXMP4的表达,分析其与患者临床病理特征的相关性。在HCCLM3和MHCC97H细胞中干扰PXMP4,在Huh7和MHCC97L细胞中过表达PXMP4,利用WB和qPCR法验证干扰/过表达效率。利用CCK-8、划痕愈合实验和Transwell侵袭实验检测干扰/过表达PXMP4对HCC细胞增殖、迁移和侵袭能力的影响,采用WB法检测干扰/过表达PXMP4或0、5、10和20 μmol/L U0126处理对HCC细胞中N-cadherin、E-cadherin、vimentin、细胞外信号调节激酶(ERK)、p-ERK表达的影响。结果:生物信息学和免疫组织化学分析显示,HCC组织中PXMP4呈高表达(P<0.05)。临床病理分析发现,PXMP4的表达与肿瘤分化程度有关联(P<0.05)。在HCC细胞中,干扰PXMP4后抑制细胞增殖、侵袭和EMT进程(P<0.05);反之,过表达PXMP4后促进HCC细胞增殖、侵袭及EMT进程(P<0.05)。此外,PXMP4通过激活ERK1/2信号通路促进HCC细胞EMT进程,U0126处理同样能够抑制HCC细胞EMT进程。结论:PXMP4在HCC组织中呈高表达且与HCC细胞分化有关联,PXMP4通过激活ERK1/2信号通路促进HCC细胞EMT进程。
5.Potential for Cefazolin as De-escalation Therapy for Klebsiella Pneumoniae Bacteraemia.
Tat Ming NG ; Christine B TENG ; Ee Ling LEW ; Li Min LING ; Brenda ANG ; David C LYE
Annals of the Academy of Medicine, Singapore 2015;44(12):571-574
Adult
;
Aged
;
Aged, 80 and over
;
Anti-Bacterial Agents
;
therapeutic use
;
Bacteremia
;
drug therapy
;
Cefazolin
;
therapeutic use
;
Drug Resistance, Bacterial
;
Female
;
Humans
;
Klebsiella Infections
;
drug therapy
;
Klebsiella pneumoniae
;
Male
;
Microbial Sensitivity Tests
;
Middle Aged
;
Retrospective Studies
;
Young Adult
6.Incomplete spondylolysis of the first sacrum: a case report.
Shi-sheng HE ; Ying-chuan ZHAO ; B J C FREEMAN ; Zhi-cai SHI ; Ming LI ; Ye ZHANG ; Lin YU
Chinese Medical Journal 2010;123(2):248-249
Adolescent
;
Female
;
Humans
;
Sacrum
;
pathology
;
surgery
;
Spondylolysis
;
diagnosis
;
pathology
;
surgery
7.Interferon beta-1b is effective and has a favourable safety profile in Chinese patients with relapsing forms of multiple sclerosis
ZX Li ; CZ Lu ; XH Zhang ; LY Cui ; XH Xu ; E Radue ; SG Chu ; LR Wang ; K Beckmann ; J Lampe ; C Pohl ; B Stemper ; R Sandbrink
Neurology Asia 2014;19(2):179-189
Background & Objective: No clinical study of any interferon beta therapy has yet been successfully conducted in Chinese multiple sclerosis patients, probably due to the low incidence of this disease in China. The primary objective of this study was to demonstrate that treating multiple sclerosis patients of Chinese origin with interferon beta-1b has a beneficial effect on disease course, as measured by the decrease of newly active lesions on magnetic resonance imaging. Methods: Chinese patients diagnosed with relapsing-remitting or secondary-progressive multiple sclerosis were enrolled in this multicenter, open label, single-arm study. Following a 3-month pre-treatment phase, patients were treated with 250 µg interferon beta-1b subcutaneously every other day for 6 months. Patients had regular assessments for treatment safety and efficacy of the treatment. Results: Thirty seven patients completed the trial. Significant decreases in the number of newly active lesions were observed in the 6-month treatment period compared with the pre-treatment period (median decrease 1.5 lesions, p<0.001). Most adverse events were mild and transient and no serious ones were observed. Conclusions: Treatment with interferon beta-1b significantly reduced the occurrence of new lesions and was well tolerated in this Chinese population. These findings support the use of interferon beta- 1b for treating Chinese MS patients.
8.Differential Analysis of Heart Rate Variability in Repeated Continuous Performance Tests Among Healthy Young Men
Chung-Chih HSU ; Tien-Yu CHEN ; Jia-Yi LI ; Terry B. J. KUO ; Cheryl C. H. YANG
Psychiatry Investigation 2025;22(2):148-155
Objective:
Executive function correlates with the parasympathetic nervous system (PNS) based on static heart rate variability (HRV) measurements. Our study advances this understanding by employing dynamic assessments of the PNS to explore and quantify its relationship with inhibitory control (IC).
Methods:
We recruited 31 men aged 20–35 years. We monitored their electrocardiogram (ECG) signals during the administration of the Conners’ Continuous Performance Test-II (CCPT-II) on a weekly basis over 2 weeks. HRV analysis was performed on ECG-derived RR intervals using 5-minute windows, each overlapping for the next 4 minutes to establish 1-minute intervals. For each time window, the HRV metrics extracted were: mean RR intervals, standard deviation of NN intervals (SDNN), low-frequency power with logarithm (lnLF), and high-frequency power with logarithm (lnHF). Each value was correlated with detectability and compared to the corresponding baseline value at t0.
Results:
Compared with the baseline level, SDNN and lnLF showed marked decreases during CCPT-II. The mean values of HRV showed significant correlation with d’, including mean SDNN (R=0.474, p=0.012), mean lnLF (R=0.390, p=0.045), and mean lnHF (R=0.400, p=0.032). In the 14th time window, the significant correlations included SDNN (R=0.578, p=0.002), lnLF (R=0.493, p=0.012), and lnHF (R=0.432, p=0.031). Significant correlation between d’ and HRV parameters emerged only during the initial CCPT-II.
Conclusion
A significant correlation between PNS and IC was observed in the first session alone. The IC in the repeated CCPT-II needs to consider the broader neural network.
9.Differential Analysis of Heart Rate Variability in Repeated Continuous Performance Tests Among Healthy Young Men
Chung-Chih HSU ; Tien-Yu CHEN ; Jia-Yi LI ; Terry B. J. KUO ; Cheryl C. H. YANG
Psychiatry Investigation 2025;22(2):148-155
Objective:
Executive function correlates with the parasympathetic nervous system (PNS) based on static heart rate variability (HRV) measurements. Our study advances this understanding by employing dynamic assessments of the PNS to explore and quantify its relationship with inhibitory control (IC).
Methods:
We recruited 31 men aged 20–35 years. We monitored their electrocardiogram (ECG) signals during the administration of the Conners’ Continuous Performance Test-II (CCPT-II) on a weekly basis over 2 weeks. HRV analysis was performed on ECG-derived RR intervals using 5-minute windows, each overlapping for the next 4 minutes to establish 1-minute intervals. For each time window, the HRV metrics extracted were: mean RR intervals, standard deviation of NN intervals (SDNN), low-frequency power with logarithm (lnLF), and high-frequency power with logarithm (lnHF). Each value was correlated with detectability and compared to the corresponding baseline value at t0.
Results:
Compared with the baseline level, SDNN and lnLF showed marked decreases during CCPT-II. The mean values of HRV showed significant correlation with d’, including mean SDNN (R=0.474, p=0.012), mean lnLF (R=0.390, p=0.045), and mean lnHF (R=0.400, p=0.032). In the 14th time window, the significant correlations included SDNN (R=0.578, p=0.002), lnLF (R=0.493, p=0.012), and lnHF (R=0.432, p=0.031). Significant correlation between d’ and HRV parameters emerged only during the initial CCPT-II.
Conclusion
A significant correlation between PNS and IC was observed in the first session alone. The IC in the repeated CCPT-II needs to consider the broader neural network.
10.Differential Analysis of Heart Rate Variability in Repeated Continuous Performance Tests Among Healthy Young Men
Chung-Chih HSU ; Tien-Yu CHEN ; Jia-Yi LI ; Terry B. J. KUO ; Cheryl C. H. YANG
Psychiatry Investigation 2025;22(2):148-155
Objective:
Executive function correlates with the parasympathetic nervous system (PNS) based on static heart rate variability (HRV) measurements. Our study advances this understanding by employing dynamic assessments of the PNS to explore and quantify its relationship with inhibitory control (IC).
Methods:
We recruited 31 men aged 20–35 years. We monitored their electrocardiogram (ECG) signals during the administration of the Conners’ Continuous Performance Test-II (CCPT-II) on a weekly basis over 2 weeks. HRV analysis was performed on ECG-derived RR intervals using 5-minute windows, each overlapping for the next 4 minutes to establish 1-minute intervals. For each time window, the HRV metrics extracted were: mean RR intervals, standard deviation of NN intervals (SDNN), low-frequency power with logarithm (lnLF), and high-frequency power with logarithm (lnHF). Each value was correlated with detectability and compared to the corresponding baseline value at t0.
Results:
Compared with the baseline level, SDNN and lnLF showed marked decreases during CCPT-II. The mean values of HRV showed significant correlation with d’, including mean SDNN (R=0.474, p=0.012), mean lnLF (R=0.390, p=0.045), and mean lnHF (R=0.400, p=0.032). In the 14th time window, the significant correlations included SDNN (R=0.578, p=0.002), lnLF (R=0.493, p=0.012), and lnHF (R=0.432, p=0.031). Significant correlation between d’ and HRV parameters emerged only during the initial CCPT-II.
Conclusion
A significant correlation between PNS and IC was observed in the first session alone. The IC in the repeated CCPT-II needs to consider the broader neural network.